| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund Ltd | 10% Owner | 2025-08-22 | 970,143 | $10.59 | $10.27MSell |
| Scott Dunseth Myers | Director | 2025-08-22 | 3,800 | $10.82 | $41.12kBuy |
| Deep Track Biotechnology Master Fund Ltd | 10% Owner | 2025-08-21 | 1,094,994 | $11.03 | $12.08MSell |
| David F. Novack | President COO | 2025-03-24 | 10,000 | $14.00 | $140.00kSell |
| David F. Novack | President COO | 2025-03-24 | 10,000 | $6.81 | $68.05kBuy |
| David F. Novack | President COO | 2025-03-18 | 14,020 | $13.58 | $190.39kSell |
| David F. Novack | President COO | 2025-03-07 | 32,764 | $14.39 | $471.47kSell |
| John L. Slebir | SVP General Counsel | 2025-02-18 | 5,358 | $12.93 | $69.28kSell |
| Ryan Spencer | CEO and Director | 2025-02-18 | 36,528 | $12.93 | $472.31kSell |
| Robert Janssen | SVP and CMO | 2025-02-18 | 4,041 | $12.93 | $52.25kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Partners L P | 21.48% | 25,226,061 | $278.75M | Insider |
| Blackrock Inc | 13.84% | 16,249,235 | $179.55M | Institution |
| Deep Track Capital LP | 13.39% | 15,726,349 | $173.78M | Institution |
| Deep Track Biotechnology Master Fund Ltd | 13.39% | 15,726,349 | $173.78M | Insider |
| Symphony Capital Partners LP | 7.69% | 9,031,431 | $99.80M | Insider |
| Vanguard Group Inc | 6.90% | 8,099,758 | $89.50M | Institution |
| James E. Flynn | 6.80% | 7,982,041 | $88.20M | Insider |
| State Street Corp | 5.35% | 6,285,477 | $69.45M | Institution |
| Millennium Management LLC | 3.86% | 4,528,415 | $50.04M | Institution |
| Chicago Capital LLC | 3.67% | 4,308,802 | $47.61M | Institution |